Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05486520 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Low-field MRI for Breast Cancer Screening

StatusEnrolling by Invitation
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 years later Sep 15, 2026 → Sep 15, 2028
See other at-risk trials from Massachusetts General Hospital

Record History

  1. Primary completion pushed from Sep 15, 2026 to Sep 15, 2028 Completion pushed from Oct 1, 2026 to Oct 1, 2028 · Eligibility criteria expanded, about 17 words Show 2 more changesShow less
    • Completion pushed from Oct 1, 2026 to Oct 1, 2028
    • Eligibility criteria expanded, about 17 words
  2. Primary completion date: Oct 15, 2023 to Sep 15, 2026 Completion date: Sep 1, 2024 to Oct 1, 2026v3 Show 1 more changeShow less
    • Completion date: Sep 1, 2024 to Oct 1, 2026
  3. Trial status: Not Yet Recruiting to Enrolling by Invitation Start date changed from estimate of Sep 2022 to Sep 1, 2022 · Site contact updatedv2 Show 2 more changesShow less
    • Start date changed from estimate of Sep 2022 to Sep 1, 2022
    • Site contact updated
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This research study wants to learn more about improving the attainable image quality for ultra-low field MRI of the breast using new data acquisition methods(also called MRI pulse sequences) and image reconstruction algorithms. For this pilot study, are testing a new method to image breast cancers at ultra-low magnetic field. The findings from this breast imaging technique will be compared with results obtained from standard mammograms, ultrasounds, MRIs, clinical examinations, and pathology evaluations, when available. The ultra-low field breast MRI performed for this study will be for research purposes and will not be used to guide clinical care.
Trial Details
NCT Number NCT05486520
Lead Sponsor Massachusetts General Hospital
Collaborators: National Institutes of Health (NIH)
Conditions Breast Benign, Malignant Neoplasm of Breast, Breast Malignant Tumor
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov